Core Laboratories Inc. (NYSE:CLB) Q1 2024 Earnings Conference Call April 25, 2024 8:30 AM ET Company Participants Larry Bruno - Chairman of the Board, President & Chief Executive Officer Gwen Gresham - Senior Vice President & Head, Investor Relations Chris Hill - Chief Financial Officer Conference Call Participants Stephen Gengaro - Stifel Operator Good morning and welcome to the Core Lab Quarter One 2024 earnings call. All participants will be in listen-only mode. [Operator Instructions] Please note this e ...

Core Laboratories (CLB) reported first-quarter 2024 adjusted earnings of 19 cents per share, which beat the Zacks Consensus Estimate of 16 cents. This can be attributed to better-than-expected performance from the Reservoir Description segment. The bottom line was in line with the year-ago quarter’s reported figure.However, this oilfield service provider’s operating revenues of $129.6 million beat the Zacks Consensus Estimate of $124 million by 4.5%. The top line increased 0.9% from the year-ago quarter’s l ...

Exhibit 99.1 FOR IMMEDIATE RELEASE CORE LAB REPORTS FIRST QUARTER 2024 RESULTS: • FIRST QUARTER REVENUE OF $129.6 MILLION, UP MODESTLY SEQUENTIALLY AND YEAROVER-YEAR • FIRST QUARTER OPERATING INCOME OF $8.6 MILLION; EX-ITEMS, $14.9 MILLION, FLAT SEQUENTIALLY, UP 3% YEAR-OVER-YEAR • FIRST QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% • FIRST QUARTER GAAP EPS OF $0.07; EX-ITEMS, $0.19, FLAT SEQUENTIALLY AND YEAR-OVERYEAR • FIRST QUARTER FREE CASH FLOW OF $2.5 MILLION • COMPANY ANNOUNCES Q2 2024 QUARTERLY DIVIDE ...

Core Laboratories (CLB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The sole determinant of the Zacks rating is a company's changing earnings picture. The Zacks Consensus Estimate -- the consensus of EPS estimates from the sell-side analysts covering the stock -- for the current and following years is tracked by the system ...

Wall Street expects a year-over-year decline in earnings on lower revenues when Core Laboratories (CLB) reports results for the quarter ended March 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on April 24. ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The research service features daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, all of which will help you become a smarter, more confident investor.It also includes access to the Zacks Style Scores.What are the Zacks Style Scores?The Zacks S ...

Risk factors associated with technology advancement our competitors' services and products. In addition, we may not be able to adapt to evolving markets and technologies, develop or acquire new services or products, or achieve and maintain technological advantages. Our success depends, in part, on our ability to obtain patents, licenses and other intellectual property rights covering our services and products. To that end, we have obtained certain patents and intend to continue to seek patents on some of ou ...

Core Laboratories Inc. (NYSE:CLB) Q4 2023 Earnings Conference Call February 1, 2024 8:30 AM ET Company Participants Lawrence Bruno - Chairman of the Board, President and Chief Executive Officer Gwen Gresham - Senior Vice President, Corporate Development and Investor Relations Christopher Hill - Senior Vice President, Chief Financial Officer Conference Call Participants Patrick Ouellette - Stifel Donald Crist - Johnson Rice and Company Operator Good morning and welcome to the Core Laboratories Fourth Quarter ...

Core Laboratories (CLB) reported fourth-quarter 2023 adjusted earnings of 19 cents per share, which missed the Zacks Consensus Estimate of 20 cents. The bottom line was also lower than the year-ago quarter’s reported figure of 20 cents. This could be attributed to poor performance in the Production Enhancement segment.However, this oilfield service provider’s operating revenues of $128 million were in line with the Zacks Consensus Estimate. The top line increased 0.3% from the year-ago quarter’s level of $1 ...

For the quarter ended December 2023, Core Laboratories (CLB) reported revenue of $128.21 million, up 0.5% over the same period last year. EPS came in at $0.19, compared to $0.20 in the year-ago quarter.The reported revenue represents a surprise of +0.32% over the Zacks Consensus Estimate of $127.8 million. With the consensus EPS estimate being $0.20, the EPS surprise was -5.00%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determ ...